#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15804	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2601	735.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1983	1983	T	994	T,G,C	991,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15804	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2601	735.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1717	1717	C	991	C,A	989,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15804	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2601	735.7	0	HET	.	.	.	A69G	.	69	69	A	602	602	A	972	A,G	757,213	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15804	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2601	735.7	0	HET	.	.	.	C262T,G,A	.	262	262	C	795	795	C	919	C,T,G,A	732,182,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27054	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3994	843.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1879	1879	A	1078	A,C,T,G	1072,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27054	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3994	843.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2513	2513	C	990	C	990	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27054	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3994	843.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2587	2587	A	959	A,T	954,3	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27054	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3994	843.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3139	3139	C	940	C,G,T	933,5,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	2290	folP	852	852	99.88	folP.l15.c4.ctg.1	2045	139.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1062	1064	AAA	213;214;213	A;A,C;A	213;212,2;213	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	2290	folP	852	852	99.88	folP.l15.c4.ctg.1	2045	139.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1293	1295	AGC	217;217;218	A;G,A;C,T	217;216,1;217,1	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5224	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3888	167.6	1	SNP	p	S91F	0	.	.	271	273	TCC	844	846	TCC	202;202;201	T;C;C	201;202;200	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5224	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3888	167.6	1	SNP	p	D95G	0	.	.	283	285	GAC	856	858	GAC	202;206;206	G,T;A;C	201,1;206;206	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5224	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3888	167.6	1	SNP	p	D95N	0	.	.	283	285	GAC	856	858	GAC	202;206;206	G,T;A;C	201,1;206;206	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2156	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1727	154.7	1	SNP	p	G45D	0	.	.	133	135	GGC	723	725	GGC	223;223;220	G;G;C	223;223;220	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1152	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1395	102.1	0	.	n	.	0	A197.	DEL	197	197	A	785	785	A	223	A	223	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5184	parC	2304	2304	99.91	parC.l6.c17.ctg.1	3376	191.0	1	SNP	p	D86N	0	.	.	256	258	GAC	789	791	GAC	224;225;225	G;A;C,G	224;225;223,2	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5184	parC	2304	2304	99.91	parC.l6.c17.ctg.1	3376	191.0	1	SNP	p	S87R	0	.	.	259	261	AGT	792	794	AGT	221;223;224	A;G;T	221;223;224	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5184	parC	2304	2304	99.91	parC.l6.c17.ctg.1	3376	191.0	1	SNP	p	S87I	0	.	.	259	261	AGT	792	794	AGT	221;223;224	A;G;T	221;223;224	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5184	parC	2304	2304	99.91	parC.l6.c17.ctg.1	3376	191.0	1	SNP	p	S87W	0	.	.	259	261	AGT	792	794	AGT	221;223;224	A;G;T	221;223;224	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5184	parC	2304	2304	99.91	parC.l6.c17.ctg.1	3376	191.0	1	SNP	p	S88P	0	.	.	262	264	TCC	795	797	TCC	225;227;226	T;C,T;C,T	225;226,1;225,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4580	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3215	177.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1883	1885	GGC	232;229;227	G;G;C,A	232;229;226,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1484	1486	GCA	271;271;273	GC,G;C;A	262,1;271;273	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1487	1489	ATC	274;276;279	A,C;T,C;C	273,1;275,1;279	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1499	1501	GTG	280;283;283	G;T;G	280;283;283	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1499	1501	GTG	280;283;283	G;T;G	280;283;283	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2003	2005	ACC	239;236;236	A;C,T;C	239;235,1;236	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2057	2059	GCG	224;225;223	G,A;C;G	223,1;225;223	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2057	2059	GCG	224;225;223	G,A;C;G	223,1;225;223	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2180	2182	GGC	234;230;231	G;G,A,C;C	234;228,1,1;231	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2189	2191	GGC	228;223;224	G;G,C;C,T	228;222,1;223,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4290	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2880	185.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2207	2209	CTG	224;230;231	C;T;G,C	224;230;230,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6194	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3561	216.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1882	1884	CCG	232;230;231	C,T;C;G	231,1;230;231	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2408	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2300	130.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	823	823	C	181	C	181	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	499	501	TTA	22;24;26	T;T;A	22;24;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	544	546	CAT	40;40;40	C,A;A;T	39,1;40;40	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	547	549	AGT	40;40;40	A;G,C;T	40;39,1;40	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	556	558	TAC	40;40;40	T,G;A;C,T,A	39,1;40;38,1,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	R307A	NONSYN	919	921	AGA	646	648	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	658	660	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	661	663	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	667	669	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	673	675	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	679	681	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	682	684	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	685	687	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	227	90.31	porB1a.l6.c30.ctg.1	857	15.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	691	693	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	540	542	GAA	271;273;270	G;A;A,C	271;273;269,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	828	830	GAT	282;282;278	G;A;T	282;282;278	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	951	953	TCA	292;293;290	T;C;A,G	292;293;289,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1080	1082	GTC	253;252;255	G,A;T;C,A	252,1;252;254,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1410	1412	GCA	273;271;272	G,T;C;A	272,1;271;272	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	1	SNP	p	G120K	1	.	.	358	360	AAG	786	788	AAG	273;272;274	A,G,C;A,C;G,A	271,1,1;271,1;273,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	1	SNP	p	A121D	1	.	.	361	363	GAC	789	791	GAC	276;277;276	G;A;C	276;277;276	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3248	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1813	219.5	1	SNP	p	D121N	0	.	.	361	363	GAC	789	791	GAC	276;277;276	G;A;C	276;277;276	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10804	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5232	257.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2178	2180	AAT	279;276;276	A,T;A;T,A	278,1;276;275,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1578	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1605	122.6	1	SNP	p	V57M	1	.	.	169	171	ATG	853	855	ATG	289;284;282	A;T;G,T	289;284;281,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
